W. Meengs

发表

Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention

A. Defranco, E. Kline-Rogers, C. Montoye, 2004, Circulation.

Frequency and prognosis of emergency coronary artery bypass grafting after percutaneous coronary intervention for acute myocardial infarction.

V. L. Clark, K. Eagle, E. Kline-Rogers, 2003, The American journal of cardiology.

Activity of Procanbid Procainamide Twice-Daily Formulation, to Suppress Ventricular Premature Depolarizations

G. Timmis, N. Kerin, H. Haber, 1997, Cardiovascular Drugs and Therapy.

Effect of pre-procedure lipid lowering therapy on in hospital mortality following percutaneous coronary interventions: an analysis of a large multicenter database

V. L. Clark, K. Eagle, A. Defranco, 2002 .

Potential bias in the use of combined end points in quality assessment of Percutaneous Coronary Interventions An analysis of the relationship between history of prior CABG and MACE

K. Eagle, D. Wennberg, D. Malenka, 2001 .

Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose.

Rosario V. Freeman, V. L. Clark, K. Eagle, 2002, The American journal of cardiology.

Peritoneal clearance of urea and potassium and protein removal during acute peritonitis in dogs.

J. Greene, J. Weller, W. Meengs, 1970, The Journal of laboratory and clinical medicine.

Simple Bedside Additive Tool for Prediction of In-Hospital Mortality After Percutaneous Coronary Interventions

Kirit Patel, Eva Kline-Rogers, K. Eagle, 2001, Circulation.

Association of a Continuous Quality Improvement Initiative With Practice and Outcome Variations of Contemporary Percutaneous Coronary Interventions

K. Eagle, Sandeep M. Jani, C. Montoye, 2006, Circulation.

The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions.

V. L. Clark, K. Eagle, E. Kline-Rogers, 2002, Journal of interventional cardiology.